Treatment of chronic lymphocytic leukemia: achieving minimal residual disease-negative status as a goal.
Montserrat
Emili
E
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D023381:Endpoint Determination; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000473:pathology*; D018365:Neoplasm, Residual; D016896:Treatment Outcome